Seven Questions For Personalized Medicine.
Michael J Joyner, Nigel Paneth
Published 2015 · Medicine
Download PDFAnalyze on Scholarcy
Personalized or precision medicine maintains that medical care and public health will be radically transformed by prevention and treatment programs more closely targeted to the individual patient. These interventions will be developed by sequencing more genomes, creating bigger biobanks, and linking biological information to health data in electronic medical records (EMRs) or obtained by monitoring technologies. Yet the assumptions underpinning personalized medicine have largely escaped questioning. In this Viewpoint, we seek to stimulate a more balanced debate by posing 7 questions for the advocates of personalized medicine.
This paper references
Aligning incentives to fulfil the promise of personalised medicine
Victor J. Dzau (2015)
Personalized Genetic Risk Counseling to Motivate Diabetes Prevention
Richard W. Grant (2012)
CYP 2 D 6 Genotype and Tamoxifen Response for Breast Cancer : A Systematic Review and Meta-Analysis
Danny W. K. Lum (2013)
Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation
Cinnamon S. Bloss (2013)
Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis.
Michael W Konstan (2007)
Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Kathleen Stergiopoulos (2014)
This paper is referenced by
Value-Based Health Care Delivery, Preventive Medicine and the Medicalization of Public Health
Andreas Vilhelmsson (2017)
Should UK primary care be an early adopter of genomic medicine?
Donna Dickenson (2019)
Personalized medicine and global health
Stefan Kohler (2017)
Clinical research in critical care. Difficulties and perspectives.
Jaime Latour-Pérez (2018)
Is the Pace of Biomedical Innovation Slowing?
Arturo Casadevall (2018)
Is It Possible to Recognize a Major Scientific Discovery?
John P. A. Ioannidis (2015)
Distrés respiratorio agudo: del síndrome a la enfermedad
Pablo Cardinal-Fernández (2016)
The Value Equation: Three complementary propositions for reconciling fidelity and adaptation in evidence-based practice implementation
Ulrica von Thiele Schwarz (2019)
Personal utility is inherent to direct-to-consumer genomic testing
Matthew Wai Heng Chung (2016)
Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century.
Jorge Alberto Bernstein Iriart (2019)
Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay.
Gabrielle Georgiou (2016)
University of Groningen A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes Hertroijs,
Martijn C G J Brouwers (2018)
Precision medicine and monoclonal antibodies: breach of promise?
Livio Garattini (2019)
Clinically Meaningful Use of Blood Tumor Markers in Oncology
Stefan Holdenrieder (2016)
Precision HIV care: responding to old questions and meeting new challenges.
Todd M. Hulgan (2018)
Ushering Hypertension Into a New Era of Precision Medicine.
Theodore Kotchen (2016)
Editors' Introduction to the Special Issue
Nigel Paneth (2018)
Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors
Florent Le Borgne (2018)
Identification of somatic mutations in thirty-year-old serum cell-free DNA from patients with breast cancer: a feasibility study
Mathilde Ritter (2020)
Molecular and genomic sciences in health: apply the established rules of evidence
Oliver Razum (2015)
Pharmacogenetics and the treatment of functional gastrointestinal disorders.
Houssam Halawi (2017)
Personalizing Medicine: Disease Prevention in silico and in socio
Sara Green (2016)
Specific Issues in Clinical Genetics and Genetic Counselling Practices Related to Inherited Cardiovascular Conditions
Angus John Clarke (2018)
Evidence-Based Precision Medicine is Needed to Move Toward General Internal Precision Medicine
Evrim Jaccard (2017)
Biomarkers and asthma management: analysis and potential applications
Levi B. Richards (2018)
Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
John S. Schneider (2016)
Translational Metabolomics: Current Challenges and Future Opportunities
Farhana R Pinu (2019)
Pharmacogenetic Testing-An Unfulfilled Promise.
Doug E Campos-Outcalt (2015)
Is There a Role for Genetics in the Prevention of Sudden Cardiac Death?
Alessandro Faragli (2016)
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future
Naomi J Rankin (2016)
Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery Disease.
Joseph A Ladapo (2017)
Offspring of Depressed Parents: 30 Years Later.
Myrna M. Weissman (2016)See more